132 related articles for article (PubMed ID: 23975871)
1. Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
Feil K; Claaßen J; Bardins S; Teufel J; Krafczyk S; Schneider E; Schniepp R; Jahn K; Kalla R; Strupp M
Neurology; 2013 Sep; 81(13):1152-8. PubMed ID: 23975871
[TBL] [Abstract][Full Text] [Related]
2. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
[TBL] [Abstract][Full Text] [Related]
3. Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
Sprenger A; Zils E; Rambold H; Sander T; Helmchen C
Ann N Y Acad Sci; 2005 Apr; 1039():395-403. PubMed ID: 15826992
[TBL] [Abstract][Full Text] [Related]
4. A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.
Claassen J; Spiegel R; Kalla R; Faldon M; Kennard C; Danchaivijitr C; Bardins S; Rettinger N; Schneider E; Brandt T; Jahn K; Teufel J; Strupp M; Bronstein A
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1392-9. PubMed ID: 23813743
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
Kalla R; Spiegel R; Claassen J; Bardins S; Hahn A; Schneider E; Rettinger N; Glasauer S; Brandt T; Strupp M
J Neuroophthalmol; 2011 Dec; 31(4):320-5. PubMed ID: 21734596
[TBL] [Abstract][Full Text] [Related]
6. Dalfampridine in patients with downbeat nystagmus--an observational study.
Claassen J; Feil K; Bardins S; Teufel J; Spiegel R; Kalla R; Schneider E; Jahn K; Schniepp R; Strupp M
J Neurol; 2013 Aug; 260(8):1992-6. PubMed ID: 23589193
[TBL] [Abstract][Full Text] [Related]
7. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.
Feil K; Bremova T; Muth C; Schniepp R; Teufel J; Strupp M
Cerebellum; 2016 Feb; 15(1):38-42. PubMed ID: 26519380
[TBL] [Abstract][Full Text] [Related]
8. Postural Ataxia in Cerebellar Downbeat Nystagmus: Its Relation to Visual, Proprioceptive and Vestibular Signals and Cerebellar Atrophy.
Helmchen C; Kirchhoff JB; Göttlich M; Sprenger A
PLoS One; 2017; 12(1):e0168808. PubMed ID: 28056109
[TBL] [Abstract][Full Text] [Related]
9. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
Strupp M; Schüler O; Krafczyk S; Jahn K; Schautzer F; Büttner U; Brandt T
Neurology; 2003 Jul; 61(2):165-70. PubMed ID: 12874393
[TBL] [Abstract][Full Text] [Related]
10. Real-time computer-based visual feedback improves visual acuity in downbeat nystagmus - a pilot study.
Teufel J; Bardins S; Spiegel R; Kremmyda O; Schneider E; Strupp M; Kalla R
J Neuroeng Rehabil; 2016 Jan; 13():1. PubMed ID: 26728632
[TBL] [Abstract][Full Text] [Related]
11. Aminopyridines for the treatment of cerebellar and ocular motor disorders.
Strupp M; Kalla R; Glasauer S; Wagner J; Hüfner K; Jahn K; Brandt T
Prog Brain Res; 2008; 171():535-41. PubMed ID: 18718350
[TBL] [Abstract][Full Text] [Related]
12. The intensity of downbeat nystagmus during daytime.
Spiegel R; Rettinger N; Kalla R; Lehnen N; Straumann D; Brandt T; Glasauer S; Strupp M
Ann N Y Acad Sci; 2009 May; 1164():293-9. PubMed ID: 19645914
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional MRIs disclose cerebellar pathologies in idiopathic downbeat nystagmus.
Hüfner K; Stephan T; Kalla R; Deutschländer A; Wagner J; Holtmannspötter M; Schulte-Altedorneburg G; Strupp M; Brandt T; Glasauer S
Neurology; 2007 Sep; 69(11):1128-35. PubMed ID: 17846412
[TBL] [Abstract][Full Text] [Related]
14. Modelling drug modulation of nystagmus.
Glasauer S; Rössert C
Prog Brain Res; 2008; 171():527-34. PubMed ID: 18718349
[TBL] [Abstract][Full Text] [Related]
15. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.
Averbuch-Heller L; Tusa RJ; Fuhry L; Rottach KG; Ganser GL; Heide W; Büttner U; Leigh RJ
Ann Neurol; 1997 Jun; 41(6):818-25. PubMed ID: 9189045
[TBL] [Abstract][Full Text] [Related]
16. Update on the pharmacotherapy of cerebellar and central vestibular disorders.
Kalla R; Teufel J; Feil K; Muth C; Strupp M
J Neurol; 2016 Apr; 263 Suppl 1():S24-9. PubMed ID: 27083881
[TBL] [Abstract][Full Text] [Related]
17. The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
Tsunemi T; Ishikawa K; Tsukui K; Sumi T; Kitamura K; Mizusawa H
J Neurol Sci; 2010 May; 292(1-2):81-4. PubMed ID: 20181362
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of idiopathic downbeat nystagmus.
Wagner J; Lehnen N; Glasauer S; Strupp M; Brandt T
Ann N Y Acad Sci; 2009 May; 1164():479-81. PubMed ID: 19645953
[TBL] [Abstract][Full Text] [Related]
19. Downbeat nystagmus: characteristics and localization of lesions.
Yee RD
Trans Am Ophthalmol Soc; 1989; 87():984-1032. PubMed ID: 2562537
[TBL] [Abstract][Full Text] [Related]
20. Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus.
Glasauer S; Strupp M; Kalla R; Büttner U; Brandt T
Ann N Y Acad Sci; 2005 Apr; 1039():528-31. PubMed ID: 15827015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
